
Cassava Sciences is scheduled to hold a corporate update on November 25th. The company, trading under the ticker $SAVA, currently has a market capitalization of $1.27 billion. There is significant anticipation and speculation surrounding the update, with some expecting negative results. The company has faced scrutiny in the past, including allegations of attempts to smear scientific integrity consultants.
Pharma bro promises to transition to a woman if $SAVA stock doesnโt crash tomorrow. ๐ฟ https://t.co/KrFUiHZcqU
๐๐ this guy has balls of steel! But I understand why he is so bearish on $SAVA https://t.co/nqJs8yLW0J
When $SAVA announces their fail tomorrow please revisit when @mattnachtrab distributed a dossier to journalists to smear scientific integrity consultant @MicrobiomDigest and was really upset when they all laughed in his face https://t.co/j2XVXuWLs1


